menu Menu Search
What are you looking for? close
RCVS Registered: 7025700
Run by a qualified team of Vets
First Class Delivery only £3.49
Next Day Delivery available
100ml Meloxidyl Oral Suspension
View Larger

100ml Meloxidyl Oral Suspension

196782

£46.26 (inc. VAT)

Meloxidyl is a non-steroidal anti-inflammatory drug (NSAID) for use in the alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders in dogs. VET PRESCRIPTION REQUIRED

Product Features

add remove
  • Pack Size: - 100ml
  • Target Animal: - Dog (Canine)
  • Pet Prescription Required?: - Yes (For UK Orders)
  • Active Ingredient: - Meloxicam
  • Product Name: - 100ml Meloxidyl Oral Suspension

More Information

add remove

Description

This medication may only be supplied with a valid veterinary prescription issued by your vet. You should only purchase this item if you have or are in the process of arranging such a prescription. See information bar for further details.  

Meloxidyl is a pale yellow suspension containing 1.5 mg/ml meloxicam as active ingredient and 2 mg/ml of sodium benzoate as a preservative. For oral application to food.

Meloxidyl Dosage and administration
To be administered orally via mixing with food. Shake well before use. Initial treatment is a single dose of 0.2 mg meloxicam/kg bodyweight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg bodyweight. Particular care should be taken with regard to the accuracy of dosing. The suspension can be given using the measuring syringes provided in the package. The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg bodyweight). Thus for the first day twice the maintenance volume will be required. The suspension could be administered using the smallest syringe for dogs less than 7 kg bodyweight (one graduation corresponding to 0.5 kg of bodyweight) or the largest syringe for dogs over 7 kg body weight (one graduation corresponding to 2.5 kg of bodyweight). A clinical response is normally seen within 3 � 4 days. Treatment should be discontinued after 10 days if no clinical improvement is apparent. Avoid the introduction of contaminants during use.

Contra-indications warnings etc
Do not use in pregnant or lactating animals. Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage impaired hepatic cardiac or renal function and haemorrhagic disorders or where there is evidence of individual hypersensitivity to the product. Do not use in dogs less than 6 weeks of age. Special precautions for use in animals If side effects occur treatment should be discontinued and the advice of a veterinarian should be sought. Avoid use in any dehydrated hypovolaemic or hypotensive animal as there is a potential risk of increased renal toxicity. In the case of overdose symptomatic treatment should be initiated. Special precautions to be taken by the person administering the veterinary medicinal product to animals People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product. In case of accidental ingestion seek medical advice immediately and show the package leaflet or label to the physician. Adverse reactions (frequency and seriousness) Typical adverse drug reactions of NSAIDs such as loss of appetite vomiting diarrhoea faecal occult blood and apathy have occasionally been reported. These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Interaction with other medicinal products and other forms of interaction Other NSAIDs diuretics anticoagulants aminoglycoside antimicrobials and substances with high protein binding may compete for binding and thus lead to toxic effects. The product must not be administered in conjunction with other NSAIDs or glucocorticosteroids. Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment. The treatment-free period however should take into account the pharmacokinetic properties of the products used previously. For animal use only. Keep out of reach and sight of children.   Pharmaceutical precautions After broaching the container the contents should be used within 6 months. If any unused product remains after this time it should be disposed of in accordance with national regulations.

Legal category
Meloxidyl is a POM-V (Pet Prescription Required)

Brand